Caplin Point Lab started business in the year 1990.
The company was listed on the stock market in 1994.
The company is also expanding rapidly in the US and the European Union.
new Delhi. When in the stock market, which stock can change the fortunes of an investor, it cannot be said. Investors who invest thoughtfully for the long term, they earn good money here. Many penny stocks in the stock market have given multibagger returns to the investors in the long term. Pharma share Caplin Point Lab Share is also a multibagger share. 20 years ago, the share price was 25 paise, which has increased to Rs 725.90 today.
It has been under selling pressure for some time now, but has made gains in the long term. It touched a one-year record high of Rs 888.45 on January 6 this year. However, after that selling dominated and by May 11, 2022 it fell 30 per cent to Rs 626.30. After this the buying trend returned and till now it has recovered 31 per cent.
The one who invested Rs 3,500 also became a millionaire.
Caplin Point Lab’s shares were available on February 21, 2003 at just 25 paise. Now it has reached Rs 725.90. In this way, this stock has jumped about 2,907 times in 20 years. This means that 20 years ago if an investor had invested Rs 3,500 in this stock and maintained his investment, he would have been a millionaire today and the value of his investment would have been Rs 1.02 crore.
Today, i.e. on Monday, December 19, the shares of Caplin Point Lab are trading at Rs 725.40, down by 0.29 per cent. This stock has declined by 1.49 percent in 1 month. In the last 6 months, this stock has given more than 14% returns. At the same time, in the year 2022, the share of Caplin Point Lab has fallen by about 17 percent.
The company was listed in 1994
Caplin Point Lab started business in 1990 and the company was listed on the stock market in 1994. Its IPO was subscribed 117 times and the money raised through the IPO was used to set up a plant at Pondipon Cheri. According to the details given on the company’s website, it is a fully integrated pharma company with presence in Latin America, French-speaking African countries. Apart from this, it is also spreading in America and European Union.
(Disclaimer: The stocks mentioned here are based on the advice of the brokerage houses. If you want to invest in any of these, first consult a certified investment advisor. News18 is not responsible for your profit or loss of any kind. Will happen.)
FIRST PUBLISHED : December 19, 2022, 12:48 IST